MedPath

Acyclovir

Approved
Approval ID

c7317324-4654-4bcc-8edf-7b7cd8794d2e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 2, 2023

Manufacturers
FDA

Modavar Pharmaceuticals LLC

DUNS: 858949204

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acyclovir

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72241-028
Application NumberANDA201445
Product Classification
M
Marketing Category
C73584
G
Generic Name
Acyclovir
Product Specifications
Route of AdministrationORAL
Effective DateMarch 2, 2023
FDA Product Classification

INGREDIENTS (8)

ACYCLOVIRActive
Quantity: 200 mg in 1 1
Code: X4HES1O11F
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acyclovir - FDA Drug Approval Details